Startup Locus Biosciences Secures $5m Convertible Note for CRISPR-Cas3 Antimicrobials

Research Triangle Park-based Locus Biosciences has secured a $5 million convertible note.

Chinese technology giant Tencent Holdings Limited led the financing round, which also included the N.C. Biotechnology Center. One of Tencent’s latest high-profile investments includes buying a 5 percent stake in electric car maker Tesla for $1.8 billion.